• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胞磷胆碱治疗病理性老年衰退中的认知和行为障碍]

[Citicoline in the treatment of cognitive and behavioral disorders in pathologic senile decline].

作者信息

Di Trapani G, Fioravanti M

机构信息

Clinica Neurologica, Università Cattolica del Sacro Cuore di Roma.

出版信息

Clin Ter. 1991 Jun 30;137(6):403-13.

PMID:1832612
Abstract

A three months study was performed on 150 aging patients with primary memory deficits in order to verify the effectiveness of CDP-Choline, administered in repeated cycles of four weeks, with an interval of one week between cycles, in improving patients' cognitive and behavioral efficiency and in stabilizing their cognitive decline. Objective measures of memory and attention, and a behavioral rating scale were used to assess treatment effects. CDP-Choline treatment demonstrated both symptomatic efficacy and a long lasting effect on cognition and behavior of these patients. Level of activation and attention responsiveness improved during treatment cycles and no further changes were identified of these variables in the follow-up period. Measures related to specific memory functioning showed, besides improvements during treatment, after-effects still active in the follow-up period, suggesting a long lasting change of the cognitive decline trend characteristic of these patients.

摘要

对150名患有原发性记忆缺陷的老年患者进行了为期三个月的研究,以验证胞磷胆碱的有效性。胞磷胆碱以四周为一个重复周期给药,周期之间间隔一周,旨在提高患者的认知和行为效率,并稳定其认知衰退。使用记忆和注意力的客观测量方法以及行为评定量表来评估治疗效果。胞磷胆碱治疗对这些患者的症状具有疗效,并且对认知和行为具有持久影响。在治疗周期中,激活水平和注意力反应性有所改善,在随访期间未发现这些变量有进一步变化。与特定记忆功能相关的测量结果显示,除了在治疗期间有所改善外,在随访期间仍有后续效应,这表明这些患者认知衰退趋势发生了持久变化。

相似文献

1
[Citicoline in the treatment of cognitive and behavioral disorders in pathologic senile decline].[胞磷胆碱治疗病理性老年衰退中的认知和行为障碍]
Clin Ter. 1991 Jun 30;137(6):403-13.
2
[Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases].[胞磷胆碱对老年精神衰退的影响。237例多中心经验]
Minerva Med. 1990 Jun;81(6):465-70.
3
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.胞二磷胆碱用于治疗老年人慢性脑部疾病相关的认知和行为障碍。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD000269. doi: 10.1002/14651858.CD000269.pub3.
4
Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.在载脂蛋白E基因分型的阿尔茨海默病患者中使用胞磷胆碱的双盲安慰剂对照研究。对认知表现、脑生物电活动和脑灌注的影响。
Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.
5
Citicoline: pharmacological and clinical review, 2006 update.胞磷胆碱:药理与临床综述,2006年更新版
Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56.
6
Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.口服胞磷胆碱的疗效与安全性。2817例药物监测研究。
Arzneimittelforschung. 1983;33(7A):1073-80.
7
CDP-choline: pharmacological and clinical review.胞磷胆碱:药理学与临床综述。
Methods Find Exp Clin Pharmacol. 1995 Oct;17 Suppl B:1-54.
8
Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.胞二磷胆碱用于治疗老年人慢性脑部疾病相关的认知和行为障碍。
Cochrane Database Syst Rev. 2000(2):CD000269. doi: 10.1002/14651858.CD000269.
9
Citicoline, use in cognitive decline: vascular and degenerative.胞磷胆碱,用于认知衰退:血管性和退行性。
J Neurol Sci. 2010 Dec 15;299(1-2):188-92. doi: 10.1016/j.jns.2010.08.027. Epub 2010 Sep 27.
10
Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.胞二磷胆碱用于治疗老年人慢性脑部疾病相关的认知和行为障碍。
Cochrane Database Syst Rev. 2000(4):CD000269. doi: 10.1002/14651858.CD000269.

引用本文的文献

1
Citicoline: pharmacological and clinical review, 2022 update.胞磷胆碱:药理学和临床综述,2022 年更新。
Rev Neurol. 2022 Nov 30;75(s05):S1-S89. doi: 10.33588/rn.75s05.2022311.